Evidence map›Paper›PMID 40242201›Full record

ArticleNanotechnology, science and applications2025

3D Computational Modeling of Fe

Piotr Gas, Muhammad Suleman, Farah Khaliq

Abstract read
In one paragraph

Article in Nanotechnology, science and applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Spatiotemporal cancer controlNanomedicine (London, England) · 2026
    Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Piotr GasDepartment of Electrical and Power Engineering, Faculty of Electrical Engineering, Automatics, Computer Science and Biomedical Engineering, AGH University of Krakow, Krakow, Poland.ORCID 0000-0003-3969-3281
Muhammad SulemanDepartment of Mathematics, Riphah Institute of Computing & Applied Sciences (RICAS), Riphah International University, Lahore, Punjab, Pakistan.ORCID 0000-0003-3286-2329
Farah KhaliqDepartment of Mathematics, Riphah Institute of Computing & Applied Sciences (RICAS), Riphah International University, Lahore, Punjab, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Nanotechnology can be used to treat a diversity of cancers with different physiological properties. Skin cancers are common among people affected by an excessive solar radiation of the ultraviolet (UV) range. Introduction: This paper describes a mathematical formulation and simulation approach for the magnetic hyperthermia therapy of skin cancer using gold-coated iron oxide (Fe Methods: The authors created an artificial 3D geometry model of skin cancer with tissue-mimicking materials, constructed a mesh, and solved all the required physics for electro-thermal simulation using FEM-based software. The heat transfer in the skin tissue was modeled using the Pennes bioheat equation, and the Helmholtz-type equation of quasi-static magnetic field produced by a three-turned coil surrounding the tumor. Results: The simulated magnetic field pattern was compared with that of the analytical solution along the symmetry axis of the helical coil with good agreement. The obtained results show that the tumor damage is maximum in the tumor center and decreases towards its outer boundaries. Additionally, the impact of varying values of blood perfusion rate, blood density, blood specific heat capacity, heat dissipation produced by Fe Conclusion: Gold-iron oxide magnetic nanoparticles succeeded to damage 90-99% skin cancer. Among all the contributing parameters, the blood perfusion is the most sensitive parameter in thermal therapy of skin tumor. Recommendations: On the bases of results obtained, we recommend physicians to use Fe

Indexed as

finite element method (FEM)gold-iron oxide magnetic nanoparticlesmagnetic hyperthermiamathematical modelingskin cancerthermal therapytumor damage

Identifiers

PMID40242201
PMCPMC12002342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.